<unk> , sold under the brand name Xigduo XR among others, is a fixed-dose combination anti-diabetic medication used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. It is a combination of dapagliflozin and metformin.<unk>  was approved for use in the European Union in January 2014, and for use in the United States in February 2014. It is taken by mouth.
Dapagliflozin/metformin
Canagliflozin/metformin
Empagliflozin/metformin
Glibenclamide/metformin
Pioglitazone/metformin
Insulin degludec/liraglutide
Dapagliflozin/saxagliptin/metformin
Sitagliptin/metformin